rdf:type |
|
lifeskim:mentions |
umls-concept:C0000962,
umls-concept:C0008976,
umls-concept:C0015502,
umls-concept:C0030705,
umls-concept:C0030797,
umls-concept:C0034656,
umls-concept:C0149531,
umls-concept:C0524865,
umls-concept:C0543467,
umls-concept:C1524063,
umls-concept:C1879547
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-7
|
pubmed:abstractText |
Activated recombinant coagulation factor VII (rFVIIa) effectively prevents and controls bleeding in patients with coagulopathy. Data show that rFVIIa may reduce blood loss and eliminate the need for transfusion in patients with normal haemostasis undergoing major surgery. We assessed the efficacy of rFVIIa in patients with normal haemostasis undergoing repair surgery of major traumatic fracture of the pelvis or the pelvis and acetabulum, who were expected to have a large volume of blood loss.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-0912
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
586-91
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15734783-Acetabulum,
pubmed-meshheading:15734783-Adolescent,
pubmed-meshheading:15734783-Adult,
pubmed-meshheading:15734783-Anticoagulants,
pubmed-meshheading:15734783-Blood Loss, Surgical,
pubmed-meshheading:15734783-Double-Blind Method,
pubmed-meshheading:15734783-Erythrocyte Transfusion,
pubmed-meshheading:15734783-Factor VII,
pubmed-meshheading:15734783-Factor VIIa,
pubmed-meshheading:15734783-Female,
pubmed-meshheading:15734783-Fractures, Bone,
pubmed-meshheading:15734783-Hemoglobins,
pubmed-meshheading:15734783-Humans,
pubmed-meshheading:15734783-Intraoperative Care,
pubmed-meshheading:15734783-Male,
pubmed-meshheading:15734783-Middle Aged,
pubmed-meshheading:15734783-Pelvic Bones,
pubmed-meshheading:15734783-Recombinant Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.
|
pubmed:affiliation |
Department of Anaesthesia and Intensive Care, St George's Hospital, London, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|